NOR-3, identified by its CAS number 138472-01-2, is a synthetic compound that belongs to the class of cannabinoids. It is a derivative of the naturally occurring cannabinoid THC (tetrahydrocannabinol) and is known for its potential pharmacological effects. NOR-3 is characterized by its ability to interact with the endocannabinoid system, particularly the cannabinoid receptors CB1 and CB2, which are involved in various physiological processes including pain sensation, mood regulation, and appetite control. The compound is often studied for its potential therapeutic applications, including analgesic and anti-inflammatory properties. However, like many synthetic cannabinoids, NOR-3 may exhibit a different safety profile and efficacy compared to its natural counterparts. Research into NOR-3 is ongoing, focusing on its biochemical mechanisms, potential benefits, and risks associated with its use. As with any cannabinoid, understanding its pharmacokinetics and pharmacodynamics is crucial for evaluating its therapeutic potential and safety in clinical applications.

NOR-3

138472-01-2: NOR-3, identified by its CAS number 138472-01-2, is a synthetic compound that belongs to the class of cannabinoids. It is a derivative of the naturally occurring cannabinoid THC (tetrahydrocannabinol) and is known for its potential pharmacological effects. NOR-3 is characterized by its ability to interact with the endocannabinoid system, particularly the cannabinoid receptors CB1 and CB2, which are involved in various physiological processes including pain sensation, mood regulation, and appetite control. The compound is often studied for its potential therapeutic applications, including analgesic and anti-inflammatory properties. However, like many synthetic cannabinoids, NOR-3 may exhibit a different safety profile and efficacy compared to its natural counterparts. Research into NOR-3 is ongoing, focusing on its biochemical mechanisms, potential benefits, and risks associated with its use. As with any cannabinoid, understanding its pharmacokinetics and pharmacodynamics is crucial for evaluating its therapeutic potential and safety in clinical applications.

CAS 138472-01-2

NOR-3

FK-409

Ref: IN-DA001TUD

(±)-(E)-4-Ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide

Ref: 7W-GK5375

FK409

Ref: TM-T31796